We are live on ! Find out more
VBA

Van Berkom & Associates Portfolio holdings

AUM $3.08B
1-Year Est. Return 12.07%
This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+12.07%
3 Year Est. Return
+35.5%
5 Year Est. Return
+48.97%
10 Year Est. Return
+344.82%
AUM
$3.44B
AUM Growth
+$141M
Cap. Flow
+$2.73M
Cap. Flow %
0.08%
Top 10 Hldgs %
27.75%
Holding
64
New
2
Increased
41
Reduced
19
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 22.99%
2 Financials 17.97%
3 Consumer Discretionary 13.09%
4 Technology 12.2%
5 Healthcare 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLCA
26
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$69.2M 2.01%
2,693,848
-29,001
-1% -$850K
TCF
27
DELISTED
TCF Financial Corporation
TCF
$67M 1.95%
2,721,379
-208,761
-7% -$5.24M
CATM
28
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$66.2M 1.93%
2,737,722
-220,355
-7% -$5.71M
REVG
29
DELISTED
REV Group
REVG
$65.8M 1.91%
3,866,342
+523,656
+16% +$9.28M
SGI
30
Somnigroup International
SGI
$14.1B
$65.5M 1.9%
5,449,464
+266,484
+5% +$3.14M
GMED icon
31
Globus Medical
GMED
$10.9B
$63.7M 1.85%
1,261,632
-124,218
-9% -$6.48M
TVTY
32
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$62.4M 1.82%
1,773,856
+1,312,287
+284% +$48.4M
SSTK icon
33
Shutterstock
SSTK
$198M
$62.3M 1.81%
1,313,332
-6,212
-0.5% -$295K
RLI icon
34
RLI Corp
RLI
$5.62B
$60.7M 1.77%
1,834,092
+12,490
+0.7% +$411K
AZZ icon
35
AZZ Inc
AZZ
$4.36B
$60.2M 1.75%
1,384,573
+9,730
+0.7% +$431K
AMBA icon
36
Ambarella
AMBA
$3.25B
$59.8M 1.74%
1,549,203
+167,095
+12% +$7.91M
MAXR
37
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$59.3M 1.72%
1,182,309
+44,272
+4% +$2.09M
THR
38
DELISTED
Thermon Group Holdings
THR
$57.9M 1.68%
2,532,067
+16,930
+0.7% +$397K
PLAY icon
39
Dave & Buster's
PLAY
$377M
$51M 1.48%
1,071,486
+277,922
+35% +$12.3M
PRKS icon
40
United Parks & Resorts
PRKS
$2.15B
$50.4M 1.47%
2,309,550
-653,633
-22% -$11.6M
UHS icon
41
Universal Health Services
UHS
$9.88B
$47.7M 1.39%
427,706
+2,324
+0.5% +$272K
MLKN icon
42
MillerKnoll
MLKN
$1.53B
$45.8M 1.33%
1,352,144
-57,691
-4% -$1.91M
WDR
43
DELISTED
Waddell & Reed Financial, Inc.
WDR
$44M 1.28%
2,447,291
+16,341
+0.7% +$318K
TCX icon
44
Tucows
TCX
$108M
$41.7M 1.21%
690,363
+29,585
+4% +$1.84M
ARA
45
DELISTED
American Renal Associates Holdings, Inc
ARA
$40.1M 1.17%
2,540,589
+34,611
+1% +$544K
DXPE icon
46
DXP Enterprises
DXPE
$2.4B
$39.4M 1.15%
1,030,415
+7,348
+0.7% +$283K
THO icon
47
Thor Industries
THO
$3.95B
$36.8M 1.07%
377,902
+6,163
+2% +$629K
STN icon
48
Stantec
STN
$7.92B
$34.4M 1%
1,340,580
+51,728
+4% +$1.31M
ADTN icon
49
Adtran
ADTN
$682M
$30.9M 0.9%
2,081,442
+13,186
+0.6% +$197K
IMAX icon
50
IMAX
IMAX
$2.61B
$29.8M 0.87%
1,345,643
+46,069
+4% +$1.03M

Similar funds

Van Berkom & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Van Berkom & Associates held 64 positions worth $3.44B, up 4.3% from $3.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Van Berkom & Associates's Q2 2018 filing shows 2 new, 41 increased, 19 reduced and 2 closed positions. Its largest new stake was Healthcare Services Group: 292,404 shares worth $12.6M. The largest sale was Chemed, an estimated $23.3M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Van Berkom & Associates's largest Q2 2018 buy was Healthcare Services Group: 292,404 shares worth $12.6M.
  • Van Berkom & Associates added most to Tivity Health, Inc. Common Stock in Q2 2018, an estimated $48.4M increase.
  • Van Berkom & Associates's biggest Q2 2018 reduction was Chemed, cutting an estimated $23.3M.
  • Van Berkom & Associates fully exited Brown & Brown in Q2 2018, selling an estimated $19.9M.
  • Van Berkom & Associates's ten largest holdings make up 28% of its $3.44B portfolio in Q2 2018.
  • Van Berkom & Associates opened 2 new positions and closed 2 in Q2 2018.
  • Van Berkom & Associates's portfolio value rose 4.3% quarter-over-quarter to $3.44B.

Based on Van Berkom & Associates's 13F filing for Q2 2018, filed 9 Aug 2018.